Skip to main content

Table 7 Model calculation

From: Diagnostic performance and inter-observer concordance in lesion detection with the automated breast volume scanner (ABVS)

 

Interpretation of the ABVS data by 2 raters

Performance of the ABVS in our study collective (n = 100)

Prevalence of disease

18.00%

SE

83.33%

SP

78.05%

Rate of second look ultrasounds in healthy women (=100%-SP)

21.95%

Estimated performance of the ABVS in a screening collective of asymptomatic women 1

Prevalence of disease 2

0.40%

PPV 3

1.49%

NPV 3

99.91%

FNR 3,4

0.09%

  1. Based on our data concerning the performance with two examiners (second-reading of the ABVS data sets), the effect in a screening setting was estimated. (SE = sensitivity; SP = specificity; PPV = positive predictive value; NPV = negative predictive value; FNR = false negative rate).
  2. 1Asymptomatic women are defined as women, who have a normal mammogram and exhibit no symptoms
  3. 2As described in the literature, the prevalence of occult carcinomas that can be detected by conventional breast ultrasound can be estimated to be about 0.4%. This value resembles the theoretical false negative rate (FNR) of clinical examination and mammography alone.
  4. 3The new performance values of the ABVS are based upon the estimated prevalence of 0.4% in a screening collective.
  5. 4The new false negative rate is based upon a combination of clinical examination, mammography and ABVS in a screening collective.